Literature DB >> 17309235

Characterization of the binding of isoniazid and analogues to Mycobacterium tuberculosis catalase-peroxidase.

Xiangbo Zhao1, Shengwei Yu, Richard S Magliozzo.   

Abstract

The first-line antituberculosis drug isonicotinic hydrazide (INH) is a prodrug whose bactericidal function requires activation by Mycobacterium tuberculosis catalase-peroxidase (KatG) to produce an acyl-NAD adduct. Peroxidation of INH is considered a required catalytic process for drug action. The binding of INH and a series of hydrazide analogues to resting KatG was examined using optical and calorimetric techniques to provide thermodynamic parameters, binding stoichiometries, and kinetic constants (on and off rates). This work revealed high-affinity binding of these substrates to a small fraction of ferric enzyme in a six-coordinate heme iron form, a species most likely containing a weakly bound water molecule, which accumulates during storage of the enzyme. The binding of hydrazides is associated with a large enthalpy loss (>100 kcal/mol); dissociation constants are in the range of 0.05-1.6 microM, and optical stopped-flow measurements demonstrated kon values in the range of 0.5-27 x 10(3) M-1 s-1 with very small koff rates. Binding parameters did not depend on pH in the range 5-8. High-affinity binding of INH is disrupted in two mutant enzymes bearing replacements of key distal side residues, KatG[W107F] and KatG[Y229F]. The rates of reduction of KatG Compound I by hydrazides parallel the on rates for association with the resting enzyme. In a KatG-mediated biomimetic activation assay, only isoniazid generated in good yield the acyl-NAD adduct which is considered a key molecule in INH action, providing a better understanding of the action mechanism of INH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309235     DOI: 10.1021/bi062218p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug.

Authors:  Tali H Reingewertz; Tom Meyer; Fiona McIntosh; Jaryd Sullivan; Michal Meir; Yung-Fu Chang; Marcel A Behr; Daniel Barkan
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

2.  Role of the oxyferrous heme intermediate and distal side adduct radical in the catalase activity of Mycobacterium tuberculosis KatG revealed by the W107F mutant.

Authors:  Xiangbo Zhao; Shengwei Yu; Kalina Ranguelova; Javier Suarez; Leonid Metlitsky; Johannes P M Schelvis; Richard S Magliozzo
Journal:  J Biol Chem       Date:  2009-01-12       Impact factor: 5.157

3.  First structural evidence for the mode of diffusion of aromatic ligands and ligand-induced closure of the hydrophobic channel in heme peroxidases.

Authors:  Amit K Singh; Nagendra Singh; Ashutosh Tiwari; Mau Sinha; Gajraj S Kushwaha; Punit Kaur; A Srinivasan; Sujata Sharma; T P Singh
Journal:  J Biol Inorg Chem       Date:  2010-05-12       Impact factor: 3.358

Review 4.  Analytical methods for kinetic studies of biological interactions: A review.

Authors:  Xiwei Zheng; Cong Bi; Zhao Li; Maria Podariu; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2015-01-27       Impact factor: 3.935

5.  Mode of binding of the tuberculosis prodrug isoniazid to heme peroxidases: binding studies and crystal structure of bovine lactoperoxidase with isoniazid at 2.7 A resolution.

Authors:  Amit K Singh; Ramasamy P Kumar; Nisha Pandey; Nagendra Singh; Mau Sinha; Asha Bhushan; Punit Kaur; Sujata Sharma; Tej P Singh
Journal:  J Biol Chem       Date:  2009-11-11       Impact factor: 5.157

6.  Nicotinohydrazide.

Authors:  Jacks P Priebe; Renata S Mello; Faruk Nome; Adailton J Bortoluzzi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2007-12-18

7.  Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG).

Authors:  Javier Suarez; Kalina Ranguelova; Johannes P M Schelvis; Richard S Magliozzo
Journal:  J Biol Chem       Date:  2009-04-09       Impact factor: 5.157

8.  The binding characteristics of isoniazid with copper-zinc superoxide dismutase and its effect on enzymatic activity.

Authors:  Nana Du; Liangquan Sheng; Zhaodi Liu; Xiaojuan Hu; Huajie Xu; Shuisheng Chen
Journal:  Chem Cent J       Date:  2013-06-06       Impact factor: 4.215

9.  Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N.

Authors:  Paolo Ascenzi; Andrea Coletta; Yu Cao; Viviana Trezza; Loris Leboffe; Gabriella Fanali; Mauro Fasano; Alessandra Pesce; Chiara Ciaccio; Stefano Marini; Massimo Coletta
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

10.  Reinvestigation of the structure-activity relationships of isoniazid.

Authors:  Pooja Hegde; Helena I M Boshoff; Yudi Rusman; Wassihun Wedajo Aragaw; Christine E Salomon; Thomas Dick; Courtney C Aldrich
Journal:  Tuberculosis (Edinb)       Date:  2021-06-05       Impact factor: 2.973

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.